| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.42▼ | 1.42▼ | 1.42▼ | 1.47▼ | 1.39▲ |
| MA10 | 1.42▼ | 1.42▼ | 1.40▲ | 1.43▼ | 1.34▲ |
| MA20 | 1.41▲ | 1.40▲ | 1.45▼ | 1.40▲ | 1.42▼ |
| MA50 | 1.42▼ | 1.47▼ | 1.45▼ | 1.36▲ | 2.36▼ |
| MA100 | 1.40▲ | 1.45▼ | 1.41▲ | 1.44▼ | 2.01▼ |
| MA200 | 1.45▼ | 1.41▲ | 1.41▲ | 2.22▼ | 1.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.007▲ | -0.003▼ | 0.002▲ | 0.057▲ |
| RSI | 48.777▼ | 47.277▼ | 44.966▼ | 50.682▲ | 39.466▼ |
| STOCH | 66.667 | 70.076 | 66.532 | 66.584 | 57.175 |
| WILL %R | -33.333 | -25.000 | -60.870 | -61.017 | -40.217 |
| CCI | 35.271 | 27.145 | 3.861 | -30.389 | 101.249▲ |
|
Thursday, April 16, 2026 06:26 AM
Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, April 14, 2026 07:41 AM
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive ...
|
|
Monday, April 13, 2026 04:02 AM
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/04/26 | 1.375 | 1.445 | 1.325 | 1.415 | 3,115,891 |
| 16/04/26 | 1.54 | 1.56 | 1.35 | 1.35 | 5,186,329 |
| 15/04/26 | 1.57 | 1.595 | 1.53 | 1.55 | 2,011,145 |
| 14/04/26 | 1.48 | 1.56 | 1.47 | 1.56 | 2,224,372 |
| 13/04/26 | 1.40 | 1.47 | 1.39 | 1.47 | 1,731,936 |
| 10/04/26 | 1.41 | 1.46 | 1.38 | 1.40 | 2,051,166 |
| 09/04/26 | 1.42 | 1.45 | 1.41 | 1.41 | 1,248,314 |
| 08/04/26 | 1.41 | 1.47 | 1.40 | 1.43 | 2,500,698 |
| 07/04/26 | 1.32 | 1.39 | 1.30 | 1.38 | 2,352,039 |
| 06/04/26 | 1.37 | 1.40 | 1.32 | 1.32 | 2,362,249 |
|
|
||||
|
|
||||
|
|